NEWS

Pfizer expands hemophilia gene therapy pipeline with $720m Sangamo deal – BioPharma-Reporter.com

BioWorld OnlinePfizer expands hemophilia gene therapy pipeline with $720m Sangamo dealBioPharma-Reporter.comThe agreement sees Pharma giant Pfizer pay Sangamo $70m upfront, but the Californian genome editing firm could receive up to $475m in milestone … Continue reading

Pfizer expands hemophilia gene therapy pipeline with $720m Sangamo deal – BioPharma-Reporter.com

BioWorld OnlinePfizer expands hemophilia gene therapy pipeline with $720m Sangamo dealBioPharma-Reporter.comThe agreement sees Pharma giant Pfizer pay Sangamo $70m upfront, but the Californian genome editing firm could receive up to $475m in milestone … Continue reading

UK’s Largest Resource of Human Stem Cells from Healthy Donors Unveiled – Technology Networks

Technology Networks

UK’s Largest Resource of Human Stem Cells from Healthy Donors Unveiled Technology Networks One of the largest sets of high quality human induced pluripotent stem cell lines from healthy individuals has been produced by a consortium involving the Wellcome Trust Sanger Institute. Comprehensively annotated and available for independent research … Global Human Embryonic Stem Cells Market 2017: Government Initiatives & Medical Tourism are Accelerating this …MilTech all 3 news articles »

Technology Networks

UK’s Largest Resource of Human Stem Cells from Healthy Donors Unveiled Technology Networks One of the largest sets of high quality human induced pluripotent stem cell lines from healthy individuals has been produced by a consortium involving the Wellcome Trust Sanger Institute. Comprehensively annotated and available for independent research … Global Human Embryonic Stem Cells Market 2017: Government Initiatives & Medical Tourism are Accelerating this …MilTech all 3 news articles »

Chaffey Breeze

CRISPR: The Future of Medicine and Human Evolution » in-Training … in-Training Humanity’s unnerving cruelty is perhaps only balanced by its kindness and innovation. It remains to be seen on which side of the scale CRISPR, a remarkable … China racing ahead to beat cancer with CRISPR gene editingecns Crispr Therapeutics AG (CRSP) CEO Rodger Novak Sells 616 …Chaffey Breeze all 3 news articles »

FDA Nod For MRK’s Keytruda, SGMO Soars On Gene Therapy Deal, OMER Catches Eyes Markets Insider Shares of Sangamo Therapeutics Inc. (SGMO) were up 44.83% to $6.30 in extended trading on Wednesday, following a global collaboration with Pfizer Inc. (PFE) for Hemophilia A gene therapy. The agreement also covers SB-525, one of Sangamo’s four lead …